Literature DB >> 20852060

Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.

Dalane W Kitzman1, Peter H Brubaker, Timothy M Morgan, Kathryn P Stewart, William C Little.   

Abstract

BACKGROUND: Heart failure (HF) with preserved left ventricular ejection fraction (HFPEF) is the most common form of HF in the older population. Exercise intolerance is the primary chronic symptom in patients with HFPEF and is a strong determinant of their reduced quality of life (QOL). Exercise training (ET) improves exercise intolerance and QOL in patients with HF with reduced ejection fraction (EF). However, the effect of ET in HFPEF has not been examined in a randomized controlled trial. METHODS AND
RESULTS: This 16-week investigation was a randomized, attention-controlled, single-blind study of medically supervised ET (3 days per week) on exercise intolerance and QOL in 53 elderly patients (mean age, 70±6 years; range, 60 to 82 years; women, 46) with isolated HFPEF (EF ≥50% and no significant coronary, valvular, or pulmonary disease). Attention controls received biweekly follow-up telephone calls. Forty-six patients completed the study (24 ET, 22 controls). Attendance at exercise sessions in the ET group was excellent (88%; range, 64% to 100%). There were no trial-related adverse events. The primary outcome of peak exercise oxygen uptake increased significantly in the ET group compared to the control group (13.8±2.5 to 16.1±2.6 mL/kg per minute [change, 2.3±2.2 mL/kg per minute] versus 12.8±2.6 to 12.5±3.4 mL/kg per minute [change, -0.3±2.1 mL/kg per minute]; P=0.0002). There were significant improvements in peak power output, exercise time, 6-minute walk distance, and ventilatory anaerobic threshold (all P<0.002). There was improvement in the physical QOL score (P=0.03) but not in the total score (P=0.11).
CONCLUSIONS: ET improves peak and submaximal exercise capacity in older patients with HFPEF.

Entities:  

Mesh:

Year:  2010        PMID: 20852060      PMCID: PMC3065299          DOI: 10.1161/CIRCHEARTFAILURE.110.958785

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  64 in total

1.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.

Authors:  Dalane W Kitzman; William C Little; Peter H Brubaker; Roger T Anderson; W Gregory Hundley; Christian T Marburger; Bridget Brosnihan; Timothy M Morgan; Kathryn P Stewart
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

2.  The pathogenesis of acute pulmonary edema associated with hypertension.

Authors:  S K Gandhi; J C Powers; A M Nomeir; K Fowle; D W Kitzman; K M Rankin; W C Little
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

3.  Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance.

Authors:  W G Hundley; D W Kitzman; T M Morgan; C A Hamilton; S N Darty; K P Stewart; D M Herrington; K M Link; W C Little
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

4.  Relation of aortic distensibility determined by magnetic resonance imaging in patients > or =60 years of age to systolic heart failure and exercise capacity.

Authors:  Pairoj Rerkpattanapipat; W Gregory Hundley; Kerry M Link; Peter H Brubaker; Craig A Hamilton; Stephen N Darty; Timothy M Morgan; Dalane W Kitzman
Journal:  Am J Cardiol       Date:  2002-12-01       Impact factor: 2.778

5.  Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study.

Authors:  R B Devereux; M J Roman; J E Liu; T K Welty; E T Lee; R Rodeheffer; R R Fabsitz; B V Howard
Journal:  Am J Cardiol       Date:  2000-11-15       Impact factor: 2.778

6.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

7.  Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.

Authors:  Philip M Mottram; Brian Haluska; Rodel Leano; Diane Cowley; Michael Stowasser; Thomas H Marwick
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

8.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).

Authors:  M F Piepoli; C Davos; D P Francis; A J S Coats
Journal:  BMJ       Date:  2004-01-16

9.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

10.  Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction.

Authors:  William C Little; Deborah J Wesley-Farrington; John Hoyle; Steffen Brucks; Scott Robertson; Dalane W Kitzman; Che-Ping Cheng
Journal:  J Cardiovasc Pharmacol       Date:  2004-02       Impact factor: 3.105

View more
  130 in total

1.  Heart failure with a normal ejection fraction: treatments for a complex syndrome?

Authors:  Samuel Bernard; Mathew S Maurer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

Review 2.  Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials.

Authors:  Ambarish Pandey; Akhil Parashar; Dharam Kumbhani; Sunil Agarwal; Jalaj Garg; Dalane Kitzman; Benjamin Levine; Mark Drazner; Jarett Berry
Journal:  Circ Heart Fail       Date:  2014-11-16       Impact factor: 8.790

Review 3.  Contemporary strategies in the diagnosis and management of heart failure.

Authors:  Shannon M Dunlay; Naveen L Pereira; Sudhir S Kushwaha
Journal:  Mayo Clin Proc       Date:  2014-03-29       Impact factor: 7.616

4.  Impact of Exercise Programs on Hospital Readmission Following Hospitalization for Heart Failure: A Systematic Review.

Authors:  Parag Goyal; Diana Delgado; Scott L Hummel; Kumar Dharmarajan
Journal:  Curr Cardiovasc Risk Rep       Date:  2016-09-09

5.  Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.

Authors:  Scott L Hummel; E Mitchell Seymour; Robert D Brook; Theodore J Kolias; Samar S Sheth; Hannah R Rosenblum; Joanna M Wells; Alan B Weder
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

6.  Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.

Authors:  Seiya Tanaka; Yoshihito Sanuki; Kiyoshi Ozumi; Takashi Harada; Hiromi Tasaki
Journal:  Heart Vessels       Date:  2018-02-01       Impact factor: 2.037

Review 7.  Current Management and Future Directions of Heart Failure With Preserved Ejection Fraction: a Contemporary Review.

Authors:  Chayakrit Krittanawong; Marrick L Kukin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

8.  Vitamin D Status and Exercise Capacity in Older Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Ambarish Pandey; Dalane W Kitzman; Denise K Houston; Haiying Chen; M Kyla Shea
Journal:  Am J Med       Date:  2018-08-01       Impact factor: 4.965

9.  Association Between 6-Minute Walk Test Distance and Objective Variables of Functional Capacity After Exercise Training in Elderly Heart Failure Patients With Preserved Ejection Fraction: A Randomized Exercise Trial.

Authors:  Sara Maldonado-Martín; Peter H Brubaker; Joel Eggebeen; Kathryn P Stewart; Dalane W Kitzman
Journal:  Arch Phys Med Rehabil       Date:  2016-09-28       Impact factor: 3.966

10.  Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.

Authors:  Muaz M Abudiab; Margaret M Redfield; Vojtech Melenovsky; Thomas P Olson; David A Kass; Bruce D Johnson; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2013-02-20       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.